INSTRUMENTS |
|
The following instruments are available to University of Minnesota (UMN) researchers for non-commercial teaching, research, and educational purposes under an Equipment Use Agreement and Exclusive Laboratory License between UMN and Photonic Pharma.
|
Equipment:
|
Fluorescence Lifetime plate reader (FLT-PR) for High-Throughput Screening (HTS)
Spectral Unmixing plate reader (SUPR)
|
|
Location:
|
Room 1-150, Nils Hasselmo Hall
University of Minnesota 312 Church Street SE Minneapolis, MN 55455 |
|
Terms of service:
|
Visit here for a summary of terms and usage fees for University of Minnesota users.
|
|
Contact us for:
|
DISCLOSURE OF CONFLICT OF INTEREST
Visit here for the Disclosure to University of Minnesota users. A summary is below.
Drs. Thomas and Cornea, in addition to their faculty positions at UMN, hold executive positions with Photonic Pharma LLC and, along with Jennifer J. Thomas, hold a majority interest in Photonic Pharma. As a result, a Conflict of Interest Management Plan (COIMP) is in place for Drs. Thomas and Cornea under the direction of BMBB Department Head (Dr. David A. Bernlohr) and the supervision of the UMN Office of Institutional Compliance, Conflict of Interest Program. The University of Minnesota holds a minority interest in Photonic Pharma under the terms of an Exclusive Patent License.
Visit here for the Disclosure to University of Minnesota users. A summary is below.
Drs. Thomas and Cornea, in addition to their faculty positions at UMN, hold executive positions with Photonic Pharma LLC and, along with Jennifer J. Thomas, hold a majority interest in Photonic Pharma. As a result, a Conflict of Interest Management Plan (COIMP) is in place for Drs. Thomas and Cornea under the direction of BMBB Department Head (Dr. David A. Bernlohr) and the supervision of the UMN Office of Institutional Compliance, Conflict of Interest Program. The University of Minnesota holds a minority interest in Photonic Pharma under the terms of an Exclusive Patent License.